NEXTBio Capital Management LP
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 2 quarters. Past performance does not predict future results.
Portfolio Concentration
24 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $215,369,990 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | +1,268,776 | 2,021,407 | $11,178,380 | |
| ZBIO | Zenas BioPharma, Inc. | +104,753 | 426,736 | $8,342,688 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +58,492 | 126,078 | $10,965,003 | |
| TERN | Terns Pharmaceuticals, Inc. | +53,344 | 604,534 | $31,871,032 | |
| GPCR | Structure Therapeutics Inc. | +38,796 | 133,239 | $6,422,119 | |
| COGT | Cogent Biosciences, Inc. | +35,369 | 131,188 | $5,049,426 | |
| IVA | Inventiva S.A. | +34,783 | 1,333,484 | $7,400,836 | |
| ZLAB | Zai Lab Ltd | +20,000 | 183,362 | $3,449,039 | |
| IRON | Disc Medicine, Inc. | +9,877 | 52,655 | $3,366,760 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −265,801 | 848,204 | $4,486,999 | |
| ORIC | Oric Pharmaceuticals, Inc. | −92,101 | 523,619 | $6,634,252 | |
| EVMN | Evommune, Inc. | −44,223 | 184,063 | $4,231,608 | |
| VSTM | Verastem, Inc. | −530 | 1,306,800 | $6,926,040 | |
| XENE | Xenon Pharmaceuticals Inc. | −479 | 183,225 | $10,654,533 | |
| PCVX | Vaxcyte, Inc. | −262 | 95,223 | $5,533,408 | |
| OCS | Oculis Holding AG | −158 | 149,592 | $3,977,651 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | 89,717 | $1,701,034 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 604,534 | $31,871,032 | 14.80% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 229,619 | $24,201,842 | 11.24% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Held | 3,149,907 | $20,253,902 | 9.40% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 999,967 | $17,839,411 | 8.28% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 2,021,407 | $11,178,380 | 5.19% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 126,078 | $10,965,003 | 5.09% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 183,225 | $10,654,533 | 4.95% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Held | 82,686 | $10,306,809 | 4.79% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Added | 426,736 | $8,342,688 | 3.87% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 1,333,484 | $7,400,836 | 3.44% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Reduced | 1,306,800 | $6,926,040 | 3.22% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 372,856 | $6,849,364 | 3.18% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 523,619 | $6,634,252 | 3.08% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 133,239 | $6,422,119 | 2.98% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 95,223 | $5,533,408 | 2.57% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 131,188 | $5,049,426 | 2.34% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 848,204 | $4,486,999 | 2.08% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Reduced | 184,063 | $4,231,608 | 1.96% | |
| OCS |
Oculis Holding AG
Healthcare
|
Reduced | 149,592 | $3,977,651 | 1.85% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 183,362 | $3,449,039 | 1.60% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 52,655 | $3,366,760 | 1.56% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Held | 131,796 | $2,653,053 | 1.23% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
NEW | 89,717 | $1,701,034 | 0.79% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 157,827 | $1,074,801 | 0.50% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.